Robert Koch

A phase III multicentre study was carried out with the GnRH agonist buserelin (Suprecur) at five university institutions (Dept. of Obstetrics and Gynaecology of Essen, Kiel, Tübingen, Münster and Erlangen) to evaluate the effect of Busereli…

MOERTEL, CHARLES G.; FLEMING, THOMAS R.; RUBIN, JOSEPH; KVOLS, LARRY K.; SARNA, GREGORY; KOCH, ROBERT; CURRIE, VIOLANTE E.; YOUNG, CHARLES W.; JONES, STEPHEN E.; DAVIGNON, J. PAUL Author Information